Need professional-grade analysis? Visit stockanalysis.com
$27.48M
N/A
N/A
N/A
Raphael Pharmaceutical Inc. (RAPH) trades on United States in USD. The company is classified in the Healthcare sector under the Medicinal Chemicals & Botanical Products industry. The stock currently trades at $1.40.
Over the past year, RAPH has traded between a low of $0.21 and a high of $1.40. The stock has gained 40.0% over this period. It is currently 561.3% above its 52-week low.
Raphael Pharmaceutical Inc. has a market capitalization of $27.48M.
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.